Pharmaceutical
- Pharmaceutical intermediates
- Heterocyclic Compound
- OLED material intermediate
- Diphenylamine intermediates
- Nutritional Supplements
- Pharmaceutical raw materials
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Urinary System Drugs
- Endocrine System
- Other
Medicine Excipients
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Pharmaceutical raw material Mupirocin Powder
Product Overview:
Mupirocin, also known as Pseudomonas aeruginosa A, is an ideal antibacterial agent for the skin surface, which was introduced to the market by GlaxoSmithKline in 1985 under the trade name of "Bactroban". The US FDA approved the use of this drug in the United States in 1987, and China approved the production and sale of this drug by CMS Pharmaceuticals in 1993. Mupirocin is mainly used for the prevention and treatment of bacterial skin infections caused by gram-positive cocci.
Pharmaceutical raw material Mupirocin Powder Attributes
CAS:12650-69-0
MF: C26H44O9
MW:500.62
EINECS:603-145-3
Specification: 99% min Mupirocin Powder
Sample:Mupirocin Powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance: White Powder
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
Pharmaceutical raw material Mupirocin Powder Details
Mupirocin Powder Usage and Synthesis.
Mupirocin, also known as Pseudomonas aeruginosa A, is an ideal antibacterial agent for the skin surface, which was introduced to the market by GlaxoSmithKline in 1985 under the trade name of "Bactroban". The US FDA approved the use of this drug in the United States in 1987, and China approved the production and sale of this drug by CMS Pharmaceuticals in 1993. Mupirocin is mainly used for the prevention and treatment of bacterial skin infections caused by gram-positive cocci.
Uses and functions of Mupirocin.
Topical antibiotic. Blocks isoleucine senescence by reversibly binding to isoleucine transfer RNA synthetase, thereby halting the synthesis of all isoleucine-containing proteins in the cell. Used for acute primary bacterial infections of the skin, such as folliculitis and impetigo.
Generally used for dermatological aspects of inflammation, eczema, etc., made into commercially available mupirocin ointment
Mupirocin is mainly used for the prevention and treatment of bacterial skin infections caused by gram-positive cocci, such as impetigo, boils, folliculitis and other primary skin infections, and eczema co-infections, ulcers co-infections, trauma co-infections and other secondary skin infections.
The main mechanism of the antibacterial effect of mupirocin is to inhibit the protein synthesis in the body of bacteria.
Pharmacological Effects Mupirocin.
Mupirocin has strong antibacterial activity against a variety of Gram-positive cocci associated with skin infections and is also effective against drug-resistant Staphylococcus aureus. It has some antibacterial effect on certain Gram-negative bacteria. No cross-resistance with other antibiotics.
Production method of Bulk Mupirocin Powder.
A group of substances produced by Pseudomonas fluorescens, including Pseudomonas acids A, B, C and D, of which mupirocin is the main metabolite Pseudomonas acid A
